Please use this identifier to cite or link to this item: https://doi.org/10.18632/oncotarget.9333
Title: The emerging roles of exosomes in leukemogeneis
Authors: Zhou, J 
Wang, S
Sun, K
Chng, W.-J 
Keywords: biological marker
galectin 3
microRNA 126
somatomedin C receptor
transforming growth factor beta receptor 1
antineoplastic agent
protein
RNA
acute myeloblastic leukemia
apoptosis
biogenesis
bone marrow biopsy
bone marrow stroma cell
cancer chemotherapy
cancer diagnosis
cancer immunotherapy
cancer prognosis
cancer resistance
cell proliferation
cell survival
chronic lymphatic leukemia
chronic myeloid leukemia
dendritic cell
drug delivery system
exosome
flow cytometry
graft versus host reaction
human
immune response
in vivo study
leukemia
leukemia cell
leukemogenesis
mesenchymal stem cell
nonhuman
Review
tumor escape
tumor microenvironment
tumor vascularization
animal
cell communication
cell motion
drug resistance
endosome
exosome
gene expression regulation
immunotherapy
leukemia
metabolism
mouse
neovascularization (pathology)
prognosis
treatment outcome
Animals
Antineoplastic Agents
Cell Communication
Cell Movement
Cell Proliferation
Cell Survival
Drug Resistance, Neoplasm
Endosomes
Exosomes
Gene Expression Regulation, Leukemic
Humans
Immunotherapy
Leukemia
Mice
Neovascularization, Pathologic
Prognosis
Proteins
RNA
Treatment Outcome
Issue Date: 2016
Citation: Zhou, J, Wang, S, Sun, K, Chng, W.-J (2016). The emerging roles of exosomes in leukemogeneis. Oncotarget 7 (31) : 50698-50707. ScholarBank@NUS Repository. https://doi.org/10.18632/oncotarget.9333
Rights: Attribution 4.0 International
Abstract: Communication between leukemia cells and their environment is essential for the development and progression of leukemia. Exosomes are microvesicles secreted by many types of cells that contain protein and RNA and mediate intercellular communication. The involvement of exosomes has been demonstrated in the crosstalk between leukemic cells, stromal cells and endothelial cells, consequently promoting the survival of leukemic cells, protection of leukemic cells from the cytotoxic effects of chemotherapeutic drugs, angiogenesis and cell migration. At the same time, exosomes can be used for the detection and monitoring of leukemia, with some advantage over current methods of detection and surveillance. As they are involved in immune response towards leukemic cells, exosomes can also potentially be exploited to augment immunotherapy in leukemia. In this review, we first describe the general characteristics of exosomes and biogenesis of exosomes. We then highlight the emerging role of exosomes in different types of leukemia. Finally, the clinical value of exosomes as biomarkers, in vivo drug carriers and novel exosome-based immunotherapy are discussed.
Source Title: Oncotarget
URI: https://scholarbank.nus.edu.sg/handle/10635/179969
ISSN: 19492553
DOI: 10.18632/oncotarget.9333
Rights: Attribution 4.0 International
Appears in Collections:Staff Publications
Elements

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_18632_oncotarget_9333.pdf963.24 kBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons